I

ICU Medical
D

ICUI

135.400
USD
-0.66
(-0.49%)
مغلق
حجم التداول
7,602
الربح لكل سهم
7
العائد الربحي
-
P/E
-35
حجم السوق
3,332,456,270
أصول ذات صلة
ABT
ABT
0.210
(0.16%)
134.280 USD
BAX
BAX
-0.450
(-1.45%)
30.660 USD
BDX
BDX
-0.560
(-0.32%)
176.660 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
COO
COO
-0.030
(-0.04%)
73.000 USD
EW
EW
-0.480
(-0.62%)
76.540 USD
ISRG
ISRG
3.16
(0.58%)
543.88 USD
MDT
MDT
-0.114
(-0.13%)
88.220 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
T
TFX
-1.540
(-1.27%)
120.020 USD
ZBH
ZBH
0.090
(0.10%)
93.600 USD
المزيد
الأخبار المقالات

العنوان: ICU Medical

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems(28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.